The stock of Apyx Medical Corp (NASDAQ: APYX) has increased by 6.51% when compared to last closing price of $2.15.Despite this, the company has seen a gain of 2.23% in its stock price over the last five trading days. prnewswire.com reported 2025-05-30 that Highlighting Real Patient Journeys and Empowering Confidence Through Loose Skin Solutions and Body Contouring CLEARWATER, Fla., May 30, 2025 /PRNewswire/ — Apyx® Medical Corporation (NASDAQ: APYX) (“Apyx Medical” or the “Company”), the manufacturer of the proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, is once again taking center stage—this time at Miami Swim Week.
Is It Worth Investing in Apyx Medical Corp (NASDAQ: APYX) Right Now?
The stock has a 36-month beta value of 1.41. Opinions on the stock are mixed, with 1 analysts rating it as a “buy”, 0 as “overweight”, 2 as “hold”, and 0 as “sell”.
The public float for APYX is 32.16M, and at present, short sellers hold a 0.66% of that float. On July 04, 2025, the average trading volume of APYX was 196.48K shares.
APYX’s Market Performance
The stock of Apyx Medical Corp (APYX) has seen a 2.23% increase in the past week, with a 41.36% rise in the past month, and a 86.18% gain in the past quarter. The volatility ratio for the week is 6.87%, and the volatility levels for the past 30 days are at 11.13% for APYX. The simple moving average for the past 20 days is 17.63% for APYX’s stock, with a 64.22% simple moving average for the past 200 days.
Analysts’ Opinion of APYX
Stephens, on the other hand, stated in their research note that they expect to see APYX reach a price target of $8. The rating they have provided for APYX stocks is “Overweight” according to the report published on July 14th, 2023.
Dougherty & Company gave a rating of “Buy” to APYX, setting the target price at $9 in the report published on April 02nd of the previous year.
APYX Trading at 45.29% from the 50-Day Moving Average
After a stumble in the market that brought APYX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.43% of loss for the given period.
Volatility was left at 11.13%, however, over the last 30 days, the volatility rate increased by 6.87%, as shares surge +37.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +142.97% upper at present.
During the last 5 trading sessions, APYX rose by +2.23%, which changed the moving average for the period of 200-days by +97.41% in comparison to the 20-day moving average, which settled at $1.95. In addition, Apyx Medical Corp saw 76.15% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at APYX starting from HILL MATTHEW C, who purchase 5,336 shares at the price of $1.13 back on Aug 13 ’24. After this action, HILL MATTHEW C now owns 7,836 shares of Apyx Medical Corp, valued at $6,030 using the latest closing price.
N/A, the N/A of Apyx Medical Corp, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for APYX
Current profitability levels for the company are sitting at:
- -0.32% for the present operating margin
- 0.52% for the gross margin
The net margin for Apyx Medical Corp stands at -0.42%. The total capital return value is set at -0.3%. Equity return is now at value -130.26%, with -30.62% for asset returns.
Based on Apyx Medical Corp (APYX), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -2.59. The debt to equity ratio resting at 0.46. The interest coverage ratio of the stock is -4.87.
Currently, EBITDA for the company is -16.8 million with net debt to EBITDA at 1.82. When we switch over and look at the enterprise to sales, we see a ratio of 1.2. The receivables turnover for the company is 4.06for trailing twelve months and the total asset turnover is 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.45.
Conclusion
To sum up, Apyx Medical Corp (APYX) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
